% | $
Quotes you view appear here for quick access.

Northwest Biotherapeutics, Inc. Message Board

steven511825 50 posts  |  Last Activity: May 27, 2016 6:18 PM Member since: Mar 12, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • steven511825 by steven511825 May 27, 2016 6:18 PM Flag

    Today the 50 has crossed the 200 DMA
    EWAve projections are to $16 ++
    FD abstract in 2 weeks
    Doublet in 10 weeks or less
    Boy out at anytime ....

    Sentiment: Strong Buy

  • steven511825 by steven511825 May 11, 2016 3:15 AM Flag

    50 DMA Crosses 100 DMA Yesterday .., buy ..

    Sentiment: Strong Buy

  • steven511825 by steven511825 May 8, 2016 6:10 PM Flag

    it will fill the gap on the upside - ill cut at $95 -
    Nil Desperandum....

    Sentiment: Strong Buy

  • Reply to

    Warrant extension !!

    by think_tank_think May 7, 2016 11:49 AM
    steven511825 steven511825 May 7, 2016 3:38 PM Flag

    2) & 3) .....I guess you meant 'Were' .....

  • steven511825 steven511825 May 6, 2016 7:09 PM Flag

    Hi Bill - Ive intentionally been ignoring fD ,I was in this for Hep C buyout from the start and my god we came close last May I have no doubt ,

    Listening to the conference with which Deshpande spoke about fD mate me realise its fD that will get the buyout over the line .

    Pharmassett for $11bn was a great deal beause GILD had the insught and the balls , JNJ need the same ,
    and I believe theyve got both .

    We will be bought by JNJ before the share price reflects game changing results CFD results and maybe at the time of the q3 triplet/ doublet data.

    Sentiment: Strong Buy

  • steven511825 by steven511825 May 5, 2016 6:32 PM Flag

    $1.5-2bn annual market EACH . and 4471 WILL BE the new SoC .
    $4bn annual x 12 P/E ,.....Results H1 - thats within 6 weeks ....

    Then the expansion of the triplet down to a doublet is not because the Triplet doesnt work ,
    its because the results are obviously off the friggin charts so much so a doublet could mean
    thats all they need . He said twice again 3102 is the only NS5a to clear 100% virus at 6 weeks...

    Thats all you need to stay long and sleep well at night ..

    Previously I thought JNJ buyout 3102 and spin off fD ... Now I believe 100%
    this is a complete buyout by JNJ this year , even Q3 . and price ??

    $10BN ++++

    alternatively this will be a $100 stock if not bought out.

    Sentiment: Strong Buy

  • Achillion Sees 3Q Phase 2B Doublet, Triplet Hep C Combo Study
    By Cristin Flanagan
    (Bloomberg) -- Achillion says partner J&J to start Phase 2b hepatitis C combination study evaluating doublet, triplet regimens for 6- and 8-weeks in 3Q.
    Sees data from doublet, triplet regimens from J&J Phase 2a study in 3Q
    Plans to initiate Phase 2 trials in paroxysmal nocturnal hemoglobinuria (PNH) after Phase 1 trial completed, sees interim data in treatment-naive patients by year end
    1Q loss/shr 13c, est. loss 14c
    Cash, equivalents $444.0m vs $460.5m q/q
    Conf. call 8:30am, 844-492-3724

    Sentiment: Strong Buy

  • May 3, 2016

    Jefferies Complement Summit

    Speaker: Milind Deshpande, Ph.D., President & CEO

    Sentiment: Strong Buy

  • steven511825 steven511825 May 2, 2016 5:29 PM Flag

    Bill if it were to only double I'd be staggered. This is minmum $4bn on good results
    On very good results we start at $5bn.

    Sentiment: Strong Buy

  • steven511825 by steven511825 May 1, 2016 5:25 AM Flag

    Showing 28 of 30 sources Recent News on Analyst Activity | NSE »
    Firm Analyst Recommendation Tgt Px Date↑ 1
    BMO Capital Markets Ian Somaiya market perform 97 04/29/16
    Morgan Stanley Matthew Harrison Equalwt/In-Line 107 04/29/16
    Goldman Sachs Dr Terence Flynn neutral/neutral 81 04/29/16
    RBC Capital Markets Michael J Yee outperform 120 04/29/16
    Credit Suisse Alethia Young outperform 120 04/29/16
    UBS Marc Goodman buy 118 04/29/16
    Needham & Co Alan Carr Phd buy 115 04/29/16
    Robert Baird Brian P Skorney outperform 135 04/29/16
    William Blair & Co John S Sonnier outperform 04/29/16
    Leerink Partners LLC Geoffrey C Porges outperform 123 04/29/16
    Cowen Dr Philip Nadeau outperform 125 04/29/16
    Morningstar, Inc Karen Andersen buy 04/29/16

  • Reply to

    What $8B could have bought

    by edvasquez Apr 29, 2016 2:01 PM
    steven511825 steven511825 Apr 29, 2016 6:55 PM Flag

    Gild shuould have bought ACHN ,short sighted smug self serving management have fooked it and are about to hand everything they ripped from JNJ straight back to them when ACHN/ ALS335 Ps2 is released

    Sentiment: Sell

  • Reply to

    Leerink Partners Target price a joke

    by robwal12700 Apr 26, 2016 4:10 PM
    steven511825 steven511825 Apr 27, 2016 10:05 AM Flag more native gamma .... you are a total idiot.. I`ve forgotten more about options than you know

    Sentiment: Strong Buy

  • ..todays close 8.36 :)

    Sentiment: Strong Buy

  • Reply to

    Shorts are nervous

    by momentum2play Apr 12, 2016 8:45 AM
    steven511825 steven511825 Apr 12, 2016 6:27 PM Flag

    Observer - agreed simply because there are far fewer shorts than the numpties herein think maybe 20%
    of what is shown as SI by the exchange .

    The shorts have had a huge result and have made friggin fortunes, straight out of Woodfords fund
    and the pension funds of many people in the UK into their pockets , and its been a masterclass by them as much as it pains me mentally and financially to say it.

    They will stay short but will have bought some OTM calls for a pitance which means they have won already and run the risk giving no more than 10% back.

    Those that talk about the shorts as if theyre going to get squeezed just show how little they know
    about how this all works - they really should not be in this kind of stock .

    The level of denial here , is bordering mental health issues , and as for I hub , its like a scene from a movie
    that crosses Groundhog Day and Nightmade on Elmstree , its truely sick stuff, the blind leading the blind constantly reasoning why the market is wrong , and never actually seeing wat is going on .

    Hopeing for the best - expecting nothing .

  • steven511825 by steven511825 Apr 12, 2016 9:10 AM Flag

    MacCugen is a total Mac Caayyuuunnttten ..

    Sentiment: Strong Buy

  • Date: 04/12/2015 - 04/12/2016 Sector Analysis | SIA »
    Short Interest 12,251,443 Short Interest Ratio

    Change in Short Interest 183,063 Change in SI Ratio
    Date↓ Short Interest Closing Price

    03/31/2016 12,251,443 1.46
    03/15/2016 12,068,380 1.44
    02/29/2016 12,023,389 1.84
    02/12/2016 11,934,225 1.97
    01/29/2016 11,722,476 2.12

  • ACHN US Equity 97) Output to Excel
    Date: 04/12/2015 - 04/12/2016 Sector Analysis | SIA »
    Short Interest 16,973,498 Short Interest Ratio
    Change in Short Interest -764,598 Change in SI Ratio
    Date Dn Short Interest Closing Price

    03/31/2016 16,973,498 7.72
    03/15/2016 17,738,096 7.14
    02/29/2016 18,078,084 7.39
    02/12/2016 18,352,332 6.07
    01/29/2016 18,336,101 6.76
    01/15/2016 19,831,924 7.56
    12/31/2015 19,640,231 10.79
    12/15/2015 20,060,042 9.71
    11/30/2015 21,099,950 10.18
    11/13/2015 21,403,080 9.97
    10/30/2015 23,949,662 7.82
    10/15/2015 25,034,708 7.60

    Sentiment: Strong Buy

  • steven511825 by steven511825 Apr 11, 2016 4:05 AM Flag

    Item 1.01. Entry into a Material Definitive Agreement
    Lease Agreement Amendment
    On April 7, 2016, Achillion Pharmaceuticals, Inc. (the “Company”) entered into Amendment No. 4 (the “Lease Amendment”) of its facility Lease Agreement, dated March 6, 2002, as previously amended by Amendment No. 1, dated September 10, 2002, Amendment No. 2, dated March 31, 2010, and Amendment No. 3, dated August 20, 2015 between the Company and WE George Street, L.L.C. (the “Landlord’) for the leased premises at 300 George Street, New Haven, Connecticut (the “300 George Street Lease”). Pursuant to the Lease Amendment, effective as of April 15, 2016 (the “Second Expansion Commencement Date”), the Company will lease an additional 2,877 rentable square feet of space at 300 George Street New Haven, Connecticut, such that the total leased premises pursuant to the 300 George Street Lease shall equal 41,509 rentable square feet. The term of the 300 George Street Lease expires March 31, 2020 (the “Termination Date”). Beginning three months from the Second Expansion Commencement Date until the Termination Date, the annual base rent shall equal $874,594.68 to be paid in monthly installments of $72,882.89. Under the Lease Amendment, the Landlord has agreed to reimburse the Company up to $42,110 for certain alterations to the leased premises, subject to certain conditions.

    Sentiment: Strong Buy

  • The first part anyway ...


    9th March 09 $2.55 ...(it had stayed at these levels for the 7 months prior )

    29th April 09 $27

    30th April 10 $57

    and you know the rest im sure ...

    Sentiment: Strong Buy

  • steven511825 steven511825 Apr 6, 2016 5:24 PM Flag

    Alas theyre not Im afraid - JNJ have a $500m option , but they will exercise it for sure ,

    We will trade $15 this quarter and $30+ in Q3 if the buy out hasnt been made public by then .

    I believe the deal is already agreed and we are simply waiting for the trial results to sign the sale .

    I believe JNJ would love fD , and that we get $5bn to $7bn for our sins...

    Sentiment: Strong Buy

0.7905+0.0005(+0.06%)May 27 4:00 PMEDT